Merck (MRK) Cash from Operations (2009 - 2026)

Merck (MRK) has reported Cash from Operations for 18 consecutive years, with $5.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Operations rose 63.07% year-over-year to $5.4 billion in Q2 2026; TTM through Jun 2026 was $20.0 billion, a 7.73% increase from a year earlier, with the FY2025 full-year figure at $16.5 billion, down 23.27% from the prior year.
• Cash from Operations was $5.4 billion for Q2 2026 at Merck, up from $3.9 billion in the prior quarter.
• Over five years, Cash from Operations peaked at $9.3 billion in Q3 2024 and troughed at $246.0 million in Q4 2023.
• A 5-year average of $4.4 billion and a median of $4.1 billion in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations tumbled 94.45% in 2023 and jumped 1302.44% in 2024, its largest moves.
• Over 5 years, Cash from Operations stood at $4.4 billion in 2022, then plunged by 94.45% to $246.0 million in 2023, then jumped by 1302.44% to $3.4 billion in 2024, then fell by 17.19% to $2.9 billion in 2025, then jumped by 87.96% to $5.4 billion in 2026.
• The last three Cash from Operations figures came in at $5.4 billion (Q2 2026), $3.9 billion (Q1 2026), and $2.9 billion (Q4 2025), per Business Quant data.